Search
for
Sort by
Research 241–270 of 1000+
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects
- Intravenous methylprednisolone pulse therapy in severe alopecia areata
- The ATP sensitive potassium channel (KATP) is a novel target for migraine drug development
- Ethinylestradiol/Chlormadinone Acetate
- Dienogest vs. combined oral contraceptive: A systematic review and meta‐analysis of efficacy and side effects to inform evidence‐based guidelines
- Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Increasing utility of finasteride for frontal fibrosing alopecia
- Two cases of stroke associated with the use of finasteride，an approved drug for male-pattern hair loss in Japan
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- SARS-CoV-2-induced Host Metabolic Reprogram (HMR): Nutritional Interventions for Global Management of COVID-19 and Post-Acute Sequelae of COVID-19 (PASC)
- Application of Kampo Medicines for Treatment of General Fatigue Due to Long COVID
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Short-Term Side Effects of Low Dose Valproate Monotherapy in Epileptic Children: A Prospective Study.
- Scalp cooling in the prevention of anthracycline-induced alopecia
- Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors
- Manifestaciones clínicas y complicaciones de la enfermedad por coronavirus 2019 (COVID-19): revisión de la literatura
- 54022 Pooled Safety Assessments from the Multinational Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials of Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata
- TRADITIONAL USES, PHYTOCHEMISTRY, AND PHARMACOLOGICAL ACTIVITIES OF AMLA WITH SPECIAL REFERENCE OF UNANI MEDICINE - AN UPDATED REVIEW
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- USE OF UPADACITINIB IN 2 CASES OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- <i>Adiantum</i> <i>capillus-veneris</i> and Respiratory Diseases
- Cross-Sectional Perspective Study of Post-COVID Syndrome Characteristics in Benghazi, Libya
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern Hair loss in Hair transplant patients using a modified delphi process
- Efficacy of Dutasteride Intradermal Injection in The Treatment of Androgenetic Alopecia
- Магний и железо как причина нарушения менструального цикла